Prospective study of the prognostic factors and clinical course in patients with Mycobacterium avium complex lung disease.

Prospective study of the prognostic factors and clinical course in patients with Mycobacterium avium complex lung disease. - Prospective study of the prognostic factors in patients with MAC lung disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019887

Enrollment

1000

Registered

2015-11-21

Start date

2015-11-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycobacterium avium complex (MAC) lung disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: aged 20 years old or over. fulfilled the criteria of MAC lung disease in 2007 ATS/IDSA criteria. within 12 months after diagnosis and untreated.

Exclusion criteria

Exclusion criteria: thirteen months or more after diagnosis or treated already.

Design outcomes

Primary

Measure	Time frame
Poor prognostic factors in patients with MAC lung disease	—

Secondary

Measure	Time frame
1)procalcitonin (PCT) value in patients with MAC lung disease 2)PCT value according to the patient's severity with MAC lung disease 3)Usefulness of the serodiagnosis of MAC lung disease and the scoring system of chest images (NICE scoring system) for assess the severity of MAC lung disease, and usefulness of serial examinations. 4)The effect of treatment timing, regimen and duration to prognosis and clinical course	—

Measure

Time frame

1)procalcitonin (PCT) value in patients with MAC lung disease 2)PCT value according to the patient's severity with MAC lung disease 3)Usefulness of the serodiagnosis of MAC lung disease and the scoring system of chest images (NICE scoring system) for assess the severity of MAC lung disease, and usefulness of serial examinations. 4)The effect of treatment timing, regimen and duration to prognosis and clinical course

—

Countries

Japan

Contacts

Public ContactAkihiro Ito

Ohara Memorial Healthcare Foundation Kurashiki Central Hospital Dept. of Respiratory Medicine

ai12306@kchnet.or.jp086-422-0210

Outcome results